Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

4D pharma to Participate in Upcoming Virtual Investor Conferences in September


4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D pharma management will present at the following virtual investor conferences:

A webcast of each presentation will be available via the ?Events' section of the 4D pharma website at www.4dpharmaplc.com. Archived replays of the webcasts will be available for 90 days following the presentation.

About 4D pharma

4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.

4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has five clinical programs, namely a Phase I/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumors, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumors, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I/II study of MRx-4DP0004 in asthma, and Blautix® in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial. Preclinical-stage programs include candidates for CNS disease such as Parkinson's disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.

For more information, refer to https://www.4dpharmaplc.com


These press releases may also interest you

at 11:28
International Forum on Lobbying and Government Relations Scheduled in Kyiv
On May 31, 2024, LOBBY CLUB, Ukraine's pioneering lobbying organization, will host the International Forum on Lobbying and Government Relations (GR). This landmark event will explore the transformative potential of lobbying following the recent...

at 11:26
Local Infusion Enters the Connecticut Market, Opens Infusion Center in Rocky Hill, the Sixth Location to Open in New England
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in Rocky Hill, Connecticut. When patients have a better experience,...

at 11:25
Simplify Healthcare Ranks No. 231 on the Financial Times List of The Americas' Fastest-Growing Companies 2024
Simplify Healthcare, a leading enterprise Payer software company, today announced that it ranks No. 231 on the prestigious Financial Times' annual ranking of The Americas' Fastest-Growing Companies 2024. The Americas' Fastest-Growing Companies 2024...

at 11:24
SOFTSWISS Invests in Largest European Social Casino
SOFTSWISS, a global tech expert with over 15 years of experience in iGaming, acquired a significant stake in Ously Games GmbH, the driving force behind the fastest-growing European social casino SpinArena.net. ...

at 11:20
Reticulate Micro Named Exclusive Supplier of Himera Tactical Radios in U.S. and with Key Government Users Globally
Reticulate Micro, Inc., a commercial and defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment, and Himera, a Ukrainian defense tech startup, announced today that the firms...

at 11:11
Cadent and Stirista Partner to Make it Easier for Marketers to Target Across Linear, Addressable, Digital and CTV
Cadent, the largest independent solutions provider for converged TV advertising, today announced a partnership with Stirista, the leading provider of data-driven marketing solutions. The agreement combines the power of Cadent Aperture Platform, the...

More news about Science and technology...


News published on and distributed by: